The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

Pacific Edge soars on busy day for NZX
Markets Market Close

Pacific Edge soars on busy day for NZX

The S&P/NZX 50 Index had a late flurry.

Graham Skellern 28 Feb 2025
Spark completes $311m sale of mobile towers to CDPQ
Markets

Spark completes $311m sale of mobile towers to CDPQ

Spark has told the NZX the deal has been completed with a sale price of $311 million.

Staff reporters 28 Feb 2025
Pacific Edge shares soar on hope for US market
Markets

Pacific Edge shares soar on hope for US market

The news should force a reconsideration by Novitas. 

Rebecca Howard 28 Feb 2025
Rocket Lab says new rocket is still on track
Markets

Rocket Lab says new rocket is still on track

CEO Peter Beck dampens down fears of a long delay and confirms a 2025 launch.

Dileepa Fonseka 28 Feb 2025